UBS AG - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 193 filers reported holding NPS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS AG ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$3,507,000
-36.6%
134,898
-19.4%
0.00%
-50.0%
Q2 2014$5,529,000
+182.8%
167,300
+156.1%
0.00%
+300.0%
Q1 2014$1,955,000
-16.9%
65,315
-15.7%
0.00%
-50.0%
Q4 2013$2,353,000
-13.9%
77,493
-9.8%
0.00%0.0%
Q3 2013$2,733,000
+223.4%
85,893
+53.5%
0.00%
+100.0%
Q2 2013$845,00055,9390.00%
Other shareholders

There were no reported owners of NPS PHARMACEUTICALS INC in Q4 2013.

NameSharesValueWeighting ↓
View complete list of NPS PHARMACEUTICALS INC shareholders